(Q44524341)

3 December 2017

title

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods (English)

1 reference

3 December 2017

0 references

1 reference

COMBINE Study Research Group

series ordinal

1

1 reference

3 December 2017

language of work or name

1 reference

1 July 2003

1 reference

Alcoholism: Clinical and Experimental Research

3 December 2017

published in

1 reference

3 December 2017

volume

27

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

1107-1122

1 reference

The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Alcoholism treatment by disulfiram and community reinforcement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Endogenous opioids are involved in the genetically determined high preference for ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

The dose-effect relationship in psychotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Pharmacotherapies for alcoholism: promising agents and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

International update: new findings on promising medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Advances in development of medications for alcoholism treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Current concepts of ethanol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Network support for drinking, Alcoholics Anonymous and long-term matching effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

In search of how people change. Applications to addictive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone blocks the post-shock increase of ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Effect of naltrexone on alcohol "high" in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

Modulation of ethanol-intake by morphine: evidence for a central site of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2003.TB02873.X

10.1111/J.1530-0277.2003.TB02873.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference